JERYL L HILLEMAN
CIK 1216628 · Chief Financial Officer · last filed 2026-07-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.86M
Companies
11
Total Filings
92
Lifetime Open-Market Net
-$9.62M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OMDA | Director | 26,655 | $23.67 | $630.9K | $0 | 9 | 2026-07-20 |
| SIBN | Director | 43,772 | $18.61 | $814.6K | -$293.0K | 11 | 2026-06-09 |
| NVCR | Director | 25,471 | $16.39 | $417.5K | -$508.0K | 13 | 2026-06-05 |
| HilleVax, Inc. (HLVX) Delisted | Director | 0 | $2.09 | $0 | $0 | 5 | 2025-09-17 |
| CUTERA INC (CUTR) Delisted | Director | — | $0.10 | — | $0 | 2 | 2024-11-05 |
| NERV | Director | 125 | $4.27 | $534 | $5.2K | 7 | 2023-09-29 |
| Talis Biomedical Corp (TLIS) Delisted | Director | — | $2.84 | — | $0 | 1 | 2021-03-18 |
| Intersect ENT, Inc. (XENT) Delisted | Chief Financial Officer | 43,836 | $28.24 | $1.24M | -$7.51M | 23 | 2019-05-08 |
| XENOPORT INC (XNPT) Delisted | Director | 0 | — | — | $0 | 11 | 2016-07-06 |
| AMYRIS, INC. (AMRS) Delisted | Chief Financial Officer | 594 | $0.05 | $30 | -$1.31M | 4 | 2011-05-23 |
| SYMYX TECHNOLOGIES INC (SMMX) Delisted | Exec. Vice President and CFO | 100,277 | — | — | $0 | 2 | 2007-03-05 |
Recent Filings · Page 9 of 10
92 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-05-23 | AMYRIS, INC. (AMRS) Delisted | Mixed | −3,599 | -$86.6K | EDGAR |
| 2011-05-20 | AMYRIS, INC. (AMRS) Delisted | Mixed | −9,401 | -$228.0K | EDGAR |
| 2011-05-12 | XENOPORT INC (XNPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-04-19 | AMYRIS, INC. (AMRS) Delisted | Mixed | −16,115 | -$867.9K | EDGAR |
| 2011-04-18 | AMYRIS, INC. (AMRS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-09-28 | — | Grant (A) | — | $0 | |
| 2010-05-12 | XENOPORT INC (XNPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-05-08 | XENOPORT INC (XNPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-05-09 | XENOPORT INC (XNPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-06-01 | XENOPORT INC (XNPT) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.